IL-38 Evaluation as a Biomarker in Pediatric Asthma

Serum Human IL-38 Levels in Asthmatic Children

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05366491

Enrollment

103

Registered

2022-05-09

Start date

2020-08-01

Completion date

2021-04-15

Last updated

2022-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Asthma

Brief summary

The aim of this study is to investigate the associations between serum IL-38 levels and different variables of asthma in children such as laboratory variables, pulmonary function test results, the diagnosis of asthma, and in correlation with disease severity.

Interventions

DIAGNOSTIC_TESTIl-38 serum level

measurement of serum levels of IL-38

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Years to 14 Years

Healthy volunteers

Yes

Inclusion criteria

* patients fulfilled the criteria of the Global Initiative for Asthma (GINA) * Age group:6-14 years

Exclusion criteria

* Malignancy * Chronic inflammatory diseases

Design outcomes

Primary

Measure	Time frame	Description
serum IL-38 levels	within 6 months	Measurement of Interleukin 38 in sera of all study subjects by ELISA

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026